Clinical Ink_Jonathan Andrus Headshot

This article features a Q&A with Jonathan Andrus, Chief Business Officer at Clinical Ink, and appeared in the October 29, 2019, issue of The Evidence Base.

In this article, you’ll learn:

  • The importance of RWE in regulatory decision making
  • How RWE challenges quality and compliance programs  
  • How the employment of RWE will change in the future